2022_Oct_PODD_Boston_ Skyscraper2


From January 2011 to September 2018, Dr John Pritchard was Director, PMO and Technology, for Philips Respironics Drug Delivery, with global accountability for the development of products for the treatment of respiratory diseases. He is now a private consultant specialising in strategic approaches to developing respiratory devices, drugs and digital health. At different stages in his career across three major pharmaceutical companies, he has been associated with the launch of 11 major products and at the Respiratory Drug Delivery (RDD) conference in April 2018, Dr Pritchard received the Charles G Thiel award for outstanding research and discovery in respiratory drug delivery. Dr Pritchard has published widely in the field, as well as having served as a board member on various scientific and industry bodies. He is currently a member of the UN Committee that makes recommendations on the essential uses of propellants.